Medication info
Pimaduo Tablet 30/2.5 mg

Pimaduo Tablet 30/2.5 mg

Prescription medicationTabletOral
Ingredient · strength
Fimasartan Potassium Trihydrate›33.005mg / 1 tabletS-Amlodipine Besylate 2.5 Hydrate›3.74mg / 1 tablet
Manufacturer / importer
Samjin Pharmaceutical Co., Ltd.
Appearance
White, rounded square film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202300138 · Approved 2023.01.06

Summary

Main use
Treatment of essential hypertension inadequately controlled with fimasartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required in elderly patients 70 years of age or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.
Child dose
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.

Ingredients

Manufacturer
Samjin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension inadequately controlled with fimasartan monotherapy

  • Essential hypertension
View approved original text

Pimasartan potassium is used for patients with essential hypertension who have difficulty in controlling blood pressure with monotherapy, helping to effectively lower blood pressure. This medication dilates blood vessels to control blood pressure, playing a crucial role in improving cardiovascular health. It is particularly suitable for hypertensive patients who do not achieve sufficient effect with monotherapy. Regular intake helps to manage blood pressure steadily. Therefore, Pimasartan potassium is used for the treatment of essential hypertension that is difficult to control.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day (e.g., in the morning), if possible. Before starting this medicine, it is recommended that the dose be adjusted using fimasartan; however, if blood pressure is not controlled as described below, a direct switch to this medicine may be considered. ㆍ 30/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 30 mg monotherapy. ㆍ 60/2.5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy. ㆍ 60/5 mg: For patients whose blood pressure is not adequately controlled with fimasartan 60 mg monotherapy or this medicine 60/2.5 mg. Patients taking fimasartan and S-amlodipine (amlodipine) concomitantly may switch to this medicine (a combination product containing the same amount of each active ingredient) for convenience. Elderly patients No initial dose adjustment is required in elderly patients 70 years of age or younger. Patients with renal impairment No dose adjustment is required in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min); however, in patients with severe renal impairment (creatinine clearance < 30 mL/min), treatment should be initiated with this medicine containing fimasartan 30 mg. Patients with hepatic impairment No dose adjustment is required in patients with mild hepatic impairment; however, this medicine should not be administered to patients with moderate to severe hepatic impairment.

Child dose

The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.

Precautions

This medication can pose a serious risk of harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients allergic to any ingredients in this medication, or those who are pregnant or breastfeeding, undergoing renal dialysis, moderate to severe hepatic impairment, biliary obstruction, diabetic patients with certain renal disorders, and patients with specific genetic lactose intolerance should not take this medication. Patients with reduced blood volume or salt deficiency, impaired renal function, renovascular hypertension, heart valve disease, severe hypotension, elderly patients, etc., should be particularly cautious during administration of this medication and should be closely monitored while taking it. This medication may cause side effects such as dizziness, headache, edema, urination disorders, insomnia, and flushing, and rarely, severe neurological, gastrointestinal, and cardiovascular adverse reactions have been reported. Patients with hypotension or electrolyte imbalances should correct these conditions before taking this medication, and the dosage should be gradually adjusted. If symptoms of hypotension appear, appropriate treatment should be sought immediately. This medication may increase serum potassium levels, so patients with heart failure or renal impairment should have regular blood tests. There may be interactions with other antihypertensives, certain diuretics, lithium, and non-steroidal anti-inflammatory drugs, so if receiving other medications, consult healthcare professionals. Pregnant or breastfeeding women should ideally avoid this medication and must consult a doctor beforehand if necessary. Safety for use in children and adolescents aged 18 and under has not been established, so it is advisable not to use it. Elderly patients can also respond sensitively to this medication, so caution is needed. Patients with severe hepatic impairment should not take this medication. In cases of overdose, hypotension, palpitations, and in severe cases shock may occur, requiring immediate emergency treatment. Keep this medication out of the reach of children and store it in its original container to maintain its quality.

Side effects

  • Dizziness
  • positional dizziness
  • headache
  • facial swelling
  • peripheral edema
  • urinary disorders
  • insomnia
  • flushing
  • syncope
  • sedation
Show 169 more
  • migraine
  • dyspepsia
  • vomiting
  • nausea
  • upper abdominal pain
  • weakness
  • foreign body sensation
  • elevated liver enzyme levels
  • decreased platelet count
  • increased serum creatine phosphokinase
  • cough
  • muscle spasm
  • musculoskeletal stiffness
  • pruritus
  • localized urticaria
  • facial flushing
  • erectile dysfunction
  • epilepsy
  • amyotrophic lateral sclerosis
  • neuropathy
  • neuronal inflammation
  • facial paralysis
  • normal pressure hydrocephalus
  • spinal stenosis
  • acute pancreatitis
  • intestinal obstruction
  • hemorrhagic duodenal ulcer
  • appendicitis
  • hemorrhoids
  • abdominal pain
  • intracranial hemorrhage
  • transient ischemic attack
  • atherosclerosis
  • exacerbation of cerebral infarction
  • cerebral hemorrhage
  • liver cancer
  • colorectal carcinoma
  • neoplasm of unspecified type
  • cervical cancer
  • prostate cancer
  • acute renal failure
  • chronic renal failure
  • kidney stones
  • pyelonephritis
  • urinary incontinence
  • rhinitis
  • pulmonary fibrosis
  • pharyngitis
  • pneumonia
  • lung disease
  • death
  • exacerbation of back pain
  • osteoarthritis
  • arthrosis
  • hypoglycemia
  • hyperkalemia
  • pulmonary embolism
  • purpura
  • bradycardia
  • atrial fibrillation
  • coronary artery disease
  • aortic stenosis
  • heart failure
  • increased blood pressure
  • acute hepatitis
  • benign pituitary neoplasm
  • otitis media
  • uterine prolapse
  • recurrent cancer
  • chest pain
  • back pain
  • edema
  • limb pain
  • neck/shoulder pain
  • fracture
  • arthralgia
  • myalgia
  • pharyngitis
  • upper respiratory infection
  • sputum
  • rhinitis
  • nosebleed
  • bronchitis
  • paresthesia
  • numbness
  • tremor
  • hypertonia
  • insomnia
  • depression
  • anxiety
  • memory impairment
  • decreased appetite
  • gastroesophageal reflux
  • gastritis
  • diarrhea
  • constipation
  • functional gastrointestinal disorder
  • difficulty urinating
  • hyperlipidemia
  • dyslipidemia
  • tinnitus
  • hearing impairment
  • hearing loss
  • pelvic inflammatory disease
  • vaginitis
  • benign prostatic hyperplasia
  • scrotal pain
  • blood pressure fluctuations
  • fatty liver
  • localized inflammation
  • soft tissue inflammation
  • lymphadenopathy
  • postoperative pain
  • allergy
  • chills
  • nasal polyps
  • pneumonia
  • hemoptysis
  • asthma
  • pulmonary granuloma
  • abnormal chest X-ray
  • rash
  • onychomycosis
  • seborrheic dermatitis
  • skin disease
  • keratosis
  • sweating
  • nail dystrophy
  • paronychia
  • contact dermatitis
  • hair loss
  • dermatitis
  • urticaria
  • toxic epidermal necrolysis
  • change in bowel habits
  • dry mouth
  • gingival hypertrophy
  • pancreatitis
  • hyperglycemia
  • tension syndrome
  • sensory impairment
  • peripheral neuropathy
  • dysgeusia
  • tremor
  • extrapyramidal disorder
  • gynecomastia
  • hypotension
  • vasculitis
  • cough
  • dyspnea
  • rash
  • angioedema
  • erythema multiforme
  • myocardial infarction
  • arrhythmia
  • thoracic pain
  • blood pressure drop
  • sinoatrial block
  • atrioventricular block
  • abdominal discomfort
  • precordial pain
  • diarrhea
  • loose stools
  • cutaneous flushing
  • maculopapular rash
  • heaviness
  • heat sensation
  • decreased glucose tolerance
  • weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light, so it should be stored in a light-blocking container. Additionally, it is important to maintain a room temperature between 1 and 30 degrees Celsius when storing the medication. Doing so will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

White, rounded square film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.